Ellington Management Group’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-10,400
| Closed | -$140K | – | 721 |
|
|
2018
Q2 | $140K | Buy |
+10,400
| New | +$140K | 0.01% | 435 |
|
|
2018
Q1 | – | Sell |
-20,600
| Closed | -$190K | – | 1050 |
|
|
2017
Q4 | $190K | Sell |
20,600
-8,700
| -30% | -$80.2K | 0.03% | 488 |
|
|
2017
Q3 | $236K | Buy |
29,300
+12,200
| +71% | +$98.3K | 0.04% | 465 |
|
|
2017
Q2 | $98K | Buy |
+17,100
| New | +$98K | 0.01% | 592 |
|